S100A11 and metabolic dysfunction-associated steatotic liver disease: S100 calcium binding protein A11 (S100A11) was upregulated in NAFLD liver, and then blocked the interaction between HDAC6 and FOXO1 to stimulate lipogenesis and liver steatosis [90].